Published in J Neurosci Res on February 15, 1999
Sex differences in autoimmune diseases. Biol Sex Differ (2011) 1.16
The effect of ageing on human lymphocyte subsets: comparison of males and females. Immun Ageing (2010) 1.14
Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice. Am J Pathol (2004) 1.01
Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest (2002) 0.95
Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J Clin Invest (2001) 0.93
Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis. Am J Pathol (2004) 0.93
Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE. Clin Exp Immunol (2005) 0.81
Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature (1989) 3.00
Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience (2008) 2.01
Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol (2001) 1.79
Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro. J Clin Invest (1981) 1.79
Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat Med (1996) 1.78
Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol (1999) 1.50
Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol (2001) 1.48
Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci U S A (1991) 1.47
Design, engineering and production of functional single-chain T cell receptor ligands. Protein Eng (1999) 1.46
Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res (1984) 1.40
Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J Immunol (2001) 1.35
T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science (1991) 1.30
Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat Med (1996) 1.25
Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol (1990) 1.20
Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol (1992) 1.20
Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules. J Neurosci Res (1989) 1.16
17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res (2001) 1.14
Specificity of T lymphocyte lines for peptides of myelin basic protein. J Immunol (1985) 1.13
Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol (1998) 1.12
Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J Immunol (1991) 1.11
Male SJL mice do not relapse after induction of EAE with PLP 139-151. J Neurosci Res (1996) 1.11
Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J Clin Invest (2000) 1.10
Association of melanoma tumor antigen activity with beta2-microglobulin. Cancer Res (1979) 1.06
Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immunodominant epitope of basic protein. J Immunol (1986) 1.04
Regulation of encephalitogenic T cells with recombinant TCR ligands. J Immunol (2000) 1.01
Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein. J Neurosci Res (1991) 1.01
A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis. J Immunol (1985) 0.99
Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells. J Immunol (1993) 0.98
Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. J Immunol (1991) 0.98
Human transfer factor: effects on lymphocyte transformation. J Immunol (1976) 0.96
Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis. J Immunol (1992) 0.96
Human transfer factor activity in the guinea pig: absence of antigen specificity. Clin Immunol Immunopathol (1977) 0.95
Inactivation of S-adenosylhomocysteine hydrolase by 5'-deoxy-5'-methylthioadenosine. Biochem Biophys Res Commun (1981) 0.95
Letter: Inhibition of lymphocyte response to stimulants induced by unsaturated fatty acids and prostaglandins. Lancet (1974) 0.95
Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol (2010) 0.93
Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J Immunol (1987) 0.93
Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis. J Immunol (1993) 0.92
Selection of encephalitogenic rat T-lymphocyte clones recognizing an immunodominant epitope on myelin basic protein. J Neurosci Res (1989) 0.92
Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides. J Immunol (1994) 0.92
Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis. J Immunol (1990) 0.92
A new orally bioavailable synthetic androstene inhibits collagen-induced arthritis in the mouse: androstene hormones as regulators of regulatory T cells. Ann N Y Acad Sci (2007) 0.92
T cell lines specific for an immunodominant epitope of human basic protein define an encephalitogenic determinant for experimental autoimmune encephalomyelitis-resistant LOU/M rats. J Immunol (1991) 0.91
Myelin basic protein specific T-helper cells induce experimental anterior uveitis. J Neurosci Res (1996) 0.90
A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. Mult Scler (2005) 0.90
Myelin basic protein specific T cell lines and clones derived from the CNS of rats with EAE only recognize encephalitogenic epitopes. J Neurosci Res (1991) 0.89
Human transfer factor: fractionation and biologic activity. J Immunol (1976) 0.88
Structural analogs of 5'-methylthioadenosine as substrates and inhibitors of 5'-methylthioadenosine phosphorylase and as inhibitors of human lymphocyte transformation. Biochem Pharmacol (1982) 0.88
Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivities. J Immunol (1979) 0.87
Protection against experimental encephalomyelitis. Idiotypic autoregulation induced by a nonencephalitogenic T cell clone expressing a cross-reactive T cell receptor V gene. J Immunol (1991) 0.87
The role of 5'-methylthioadenosine phosphorylase in 5'-methylthioadenosine-mediated inhibition of lymphocyte transformation. Biochim Biophys Acta (1979) 0.87
TCR peptide therapy in human autoimmune diseases. Neurochem Res (2001) 0.87
OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis. J Neurosci Res (1996) 0.86
Immunoregulation of encephalitogenic MBP-NAc1-11-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma. Autoimmunity (1999) 0.85
The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells. Int Immunol (1998) 0.85
IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R alpha and gamma chains. J Neuroimmunol (1999) 0.85
T cell receptor peptides in treatment of autoimmune disease: rationale and potential. J Neurosci Res (1996) 0.85